Immunohistochemistry in screening for heritable colorectal cancer

what to do with an abnormal result

Steven R. Paredes*, Charles Chan, Matthew J. F. X. Rickard

*Corresponding author for this work

Research output: Contribution to journalReview article

Abstract

Recent developments in our understanding of molecular genetics have transformed screening and diagnostic practices for Lynch syndrome. The current standard involves universal tumour analysis of resected colorectal cancer (and ideally polypectomy) specimens using immunohistochemistry and molecular techniques. Patients with abnormal immunohistochemical findings are subsequently referred for definitive mutational testing. This review relates the molecular pathogenesis of Lynch syndrome to current immunohistochemistry-based screening strategies and discusses the interpretation and clinical implications of screening results.

Original languageEnglish
Pages (from-to)702-707
Number of pages6
JournalANZ Journal of Surgery
Volume90
Issue number5
DOIs
Publication statusPublished - 1 May 2020

Keywords

  • cancer screening
  • colorectal cancer
  • colorectal surgery
  • hereditary cancer
  • immunohistochemistry
  • Lynch syndrome

Fingerprint Dive into the research topics of 'Immunohistochemistry in screening for heritable colorectal cancer: what to do with an abnormal result'. Together they form a unique fingerprint.

  • Cite this